Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Moe

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 11, 2025
Predicting drug overdose and death after "before medically advised" hospital dischargeHiten Naik, Daniel Daly-Grafstein, Xiao Hu, et al.
Substance Abuse Treatment, Prevention, and Policy|July 7, 2023
Association between toxic drug events and encephalopathy in British Columbia, Canada: a cross-sectional analysisChloé G Xavier, Margot Kuo, Roshni Desai, et al.
CJEM|August 22, 2023
Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packsKevin Duncan, Frank Scheuermeyer, Daniel Lane, et al.
Journal of the American College of Emergency Physicians Open|January 4, 2021
Microdosing and standard-dosing take-home buprenorphine from the emergency department: A feasibility studyJessica Moe, Katherin Badke, Megan Pratt, et al.
Substance Abuse Treatment, Prevention, and Policy|February 21, 2024
An emergency-department-initiated outreach program for patients with opioid use disorder is associated with an increase in agonist therapy and engagement in addictions care: a one-year cohort studyRukaiyah Lakkadghatwala, Daniel Lane, Frank Scheuermeyer, et al.
Annals of Emergency Medicine|August 2, 2020
Lorazepam Versus Diazepam in the Management of Emergency Department Patients With Alcohol WithdrawalFrank X Scheuermeyer, Isabelle Miles, Daniel J Lane, et al.
Clinical Toxicology (Philadelphia, Pa.)|May 14, 2020
Comparison of rates of opioid withdrawal symptoms and reversal of opioid toxicity in patients treated with two naloxone dosing regimens: a retrospective cohort studyRoy Purssell, Jesse Godwin, Jessica Moe, et al.
Addiction Science & Clinical Practice|February 13, 2021
Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trialJames S H Wong, Mohammadali Nikoo, Jean N Westenberg, et al.
Annals of Emergency Medicine|March 26, 2023
Qualitative Exploration of Emergency Department Care Experiences Among People With Opioid Use DisorderLexis R Galarneau, Frank X Scheuermeyer, Jesse Hilburt, et al.
Plos One|July 29, 2021
Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative studyLexis R Galarneau, Jesse Hilburt, Zoe R O'Neill, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 11, 2025
Predicting drug overdose and death after "before medically advised" hospital dischargeHiten Naik, Daniel Daly-Grafstein, Xiao Hu, et al.
Substance Abuse Treatment, Prevention, and Policy|July 7, 2023
Association between toxic drug events and encephalopathy in British Columbia, Canada: a cross-sectional analysisChloé G Xavier, Margot Kuo, Roshni Desai, et al.
CJEM|August 22, 2023
Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packsKevin Duncan, Frank Scheuermeyer, Daniel Lane, et al.
Journal of the American College of Emergency Physicians Open|January 4, 2021
Microdosing and standard-dosing take-home buprenorphine from the emergency department: A feasibility studyJessica Moe, Katherin Badke, Megan Pratt, et al.
Substance Abuse Treatment, Prevention, and Policy|February 21, 2024
An emergency-department-initiated outreach program for patients with opioid use disorder is associated with an increase in agonist therapy and engagement in addictions care: a one-year cohort studyRukaiyah Lakkadghatwala, Daniel Lane, Frank Scheuermeyer, et al.
Annals of Emergency Medicine|August 2, 2020
Lorazepam Versus Diazepam in the Management of Emergency Department Patients With Alcohol WithdrawalFrank X Scheuermeyer, Isabelle Miles, Daniel J Lane, et al.
Clinical Toxicology (Philadelphia, Pa.)|May 14, 2020
Comparison of rates of opioid withdrawal symptoms and reversal of opioid toxicity in patients treated with two naloxone dosing regimens: a retrospective cohort studyRoy Purssell, Jesse Godwin, Jessica Moe, et al.
Addiction Science & Clinical Practice|February 13, 2021
Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trialJames S H Wong, Mohammadali Nikoo, Jean N Westenberg, et al.
Annals of Emergency Medicine|March 26, 2023
Qualitative Exploration of Emergency Department Care Experiences Among People With Opioid Use DisorderLexis R Galarneau, Frank X Scheuermeyer, Jesse Hilburt, et al.
Plos One|July 29, 2021
Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative studyLexis R Galarneau, Jesse Hilburt, Zoe R O'Neill, et al.
Pageof 7